The antioxidative effect of conjugated linoleic acid (CLA) was examined by determining lipid peroxidation and antioxidative enzyme activities. Male Sprague-Dawley rats were fed one of the experimental diets-normal diet, vitamin E-deficient control diet, 0.5% CLA vitamin E-deficient diet, or 1.5% CLA vitamin E-deficient diet for 5wk. Hepatic thiobarbituric acid reactive substances (TSARS) were increased in the vitamin E-deficient control group, but they were was significantly lowered in the CLA groups. Similarly, hepatic glutathione peroxidase activity was increased in the vitamin E-deficient diet and reduced by CLA supplementation. In addition, CLA caused a significant decrease in superoxide dismu tase activity while having no effect on catalase activity. Analyses of the fatty acid composi tion revealed that dietary CLA was incorporated into hepatic microsomal membrane dose dependently. Compared to the vitamin E-deficient control, CLA resulted in significantly higher saturated and monounsaturated fatty acids (palmitic and oleic acids) while lowering levels of oxidation-susceptible polyunsaturated fatty acids (linoleic, linolenic, and arachi donic acids) in both plasma and hepatic membrane. The concentrations of plasma choles terol and triacylglycerol (TG) were lower in the 1.5% CLA group than in other groups. These results suggest that dietary CLA has antiatherosclerotic and antioxidant activity by increas ing oxidative stability in plasma and hepatic membrane in the vitamin E-deficient rats.
Conjugated
reported that CLA did not act as an effective radical scavenger and metal chelator, using a phosphatidylcho line liposome model system (8) . This result indicated that CLA acted similar to other polyunsaturated fatty acids under oxidative stress. Thus, it appears that the experimental evidence is insufficient to substantiate CLA as an antioxidant. It was reported that dietary CLA can reduce athero genic risk by decreasing plasma triacylglycerol, total and LDL-cholesterol levels (2, 5) . The plasma triacylg lycerol and lipoproteins are synthesized mainly in the liver. Microsomes contain fatty acid desaturases and the enzymes catalyzing the synthesis of phosphatidic acid, a key intermediate in both triacylglycerol and phospho lipids synthesis. Membrane fatty acids serve as modula tors of the biological processes such as eicosanoid pro duction and activation of membrane-bound enzymes (9, 10) . Therefore, study of the fatty acid composition of the hepatic membrane is thought to be important for understanding the effect of dietary CLA on plasma lip ids. Dietary CLA could also result in changes in lipid peroxidation by altering fatty acid composition. How ever, studies have not been performed to determine whether the effect of CLA on plasma lipid and lipid per oxidation is mediated through alteration in the fatty * To whom correspondence should be addressed .
E-mail; tyhap@kfri.re.kr peroxide content. Lipid peroxidation in liver was deter mined by the production of TBARS according to the method of Ohkawa et al. (19) . Malondialdehyde, which has been identified as the product of lipid peroxidation, reacted with thiobarbituric acid and the absorbance was determined at 532nm. Statistical analysis. All statistical analyses were car ried out using ANOVA and Duncan's multiple range test; a p value of<0.05 was selected as the limit of sta tistical significance. The statistical program used was SAS package (Cary, NC, USA).
RESULTS

Diet consumption, growth, and tissue weight
There were no significant differences in the diet intakes among the experimental groups. However, final body weight and food efficiency ratio were lower in CLA groups than in the control group (Table 2 ). In contrast, the CLA diets caused the increase of liver weight with out any differences in the weights of other organs. A significant hepatomegaly was observed in the CLA groups as indicated by the relative liver weight to body weight. Lipid parameters in plasma and the activities of AST and ALT
The effects of dietary CLA on plasma lipid level are summarized in Table 3 . The concentrations of triacylg lycerol and total cholesterol were affected by dietary Table  2 .
treatments, in contrast to the absence of differences in HDL-cholesterol and phospholipid. The CLA diets tended to lower triacylglycerol and total cholesterol lev els compared with the vitamin-E free control diet, and the reduction was statistically significant at the level of 1.5 wt%.
The activities of AST and ALT are also represented in Tables 4 and 5 as the percentage of total fatty acids. Dietary CLA was incor porated into the plasma and hepatic microsome, espe cially dose-dependently in the hepatic microsomal frac tion. The CLA diets affect the composition of other major fatty acids, in contrast to the similar composition between normal basal diet-fed group and vitamin E-free control diet-fed group. In the CLA-fed groups , linoleic Table  2 .
and arachidonic acids were decreased while oleic acid was increased in both plasma and hepatic microsome. In addition, total content of polyunsaturated fatty acids was significantly reduced but those of saturated and monounsaturated fatty acids were elevated in both plasma and hepatic microsome. Lipid peroxidation and the activities of antioxidant enzymes Concentrations of plasma and hepatic TBARS, as an estimate of lipid peroxidation, are shown in Fig. 1 . When compared with the normal basal diet, the vita min E-free control diet resulted in an elevated TBARS level. However, the CLA diets lowered the hepatic TBARS level significantly, even though it could not reach the level of the normal basal group. Plasma TBARS levels were comparable among the vitamin E free experimental groups. The activities of antioxidant enzymes in hepatic tissue are represented in Table 6 . SOD activity was significantly greater in rats fed the vitamin E-free control diet, which was restored to the normal basal level by feeding of CLA. GSH-Px activity was low in vitamin E-free diet-fed rats, compared with the rats fed the normal basal diet. The CLA diet increased the activity of GSH-Px, even though it could not reach the level of the normal basal group. The cata lase activity did not show any difference among the The hepatomegaly and concomitant enlargement of spleen was also observed in other studies and have raised safety issues. The tissue examination did not show any severe pathologic changes but increased lipid droplets in the liver and spleen (24) (25) (26) . However, the cellular and molecular mechanism involved in this pro cess are not well known. It has been suggested that fatty liver could be a consequence of the increased lipo genesis in the liver in compensating for the reduction of fat deposition in the adipose tissue (25, 27) . Numerous studies have documented that CLA has antiatherogenic activity in human and experimental animal (2, 5, 28) by decreasing plasma lipid levels. Con sistent with these findings, the present study demon strates that CLA at 1.5wt% significantly reduced the level of total cholesterol and triacylglycerol. It has been demonstrated that free radical-mediated oxidative stress implicated the genesis and progression of atherosclero sis (29) . The stress results from the imbalance between the productiooooo of free radicals and effectiveness of the antioxidant defense system. The activity of free radicals is countered by a system of antioxidant defenses. There fore, the antioxidant activity of CLA has been investi gated as a possible mechanism by several research groups but they reported conflicting results (6) (7) (8) . Most studies were conducted in vitro and used a defined car cinogenic model system. However, there has been lim ited information about the effect of CLA on lipid peroxi dation in normal liver tissue, even though PUPA taken into the body was mostly delivered to liver cells and liver is one of the principal targets of PUPA peroxidative effects (30) . Our major concern was whether CLA acts in a protective role against oxidative damage in hepatic tissue, with respect to antiatherosclerosis. Among the experimental oxidative stress models, vitamin E-defi cient diets have been well investigated in animals. In these animals, there is a deficiency of vitamin E in the cell membrane and decreased antioxidative status in the lipid bilayers, and severe membrane damage occurs (31) . We used a vitamin E-free diet to induce peroxida tive damage as a control and compared the effect of CLA supplementation.
In our study, the concentration of plasma and hepatic TBARS was increased in the vitamin E-free control diet group compared to the vitamin E-supplemented normal group, which indicates the stimulation of tissue lipid peroxidation due to oxidative stress. In contrast, TBARS production was reduced by the intake of CLA in a dose dependent manner in hepatic microsome, whereas it had no effect in the concentration of plasma TBARS. The CLA concentration in the plasma and hepatic microsome fraction suggests that CLA was absorbed and distributed to the liver more than plasma. However, further investigation is required to determine why TBARS in plasma does not respond to a high dose of dietary CLA.
In addition, dietary CLA protected liver tissue from peroxidative damage, which is supported by the assay of enzymes related to the liver disease. Feeding of the vita min E-free control diet increased the activities of AST are of particular importance. Considering that the accumulation of PUPA such as arachidonic acid poten tiates the susceptibility to peroxidation, it is noteworthy that CLA alters the fatty acid composition of biological tissue in a manner increasing oxidative stability. In addition, the decrease of arachidonic acid content sug gests that the subsequent decreased synthesis of arachi donate-derived eicosanoid production may play a role in the antiatherogenic effect observed in CLA-fed rats. In summary, we found that the ability of CLA to decrease polyenoic fatty acid concentration in both plasma and hepatic membrane, with the antioxidant sparing property, could decrease the formation of dele terious lipid peroxidation product in vitamin E-deficient rats.
